{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:24:26Z","timestamp":1786933466059,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06102-2","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T03:13:53Z","timestamp":1781147633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum asprosin levels as a subclinical atherosclerosis marker in patients with primary hypertension"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6632-7044","authenticated-orcid":false,"given":"Mehmet \u0130brahim","family":"\u00d6zet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8469-0907","authenticated-orcid":false,"given":"Fatih","family":"Acehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7391-5541","authenticated-orcid":false,"given":"Merve","family":"Kayg\u0131s\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2648-5791","authenticated-orcid":false,"given":"Mustafa Abdulgani","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6552-1275","authenticated-orcid":false,"given":"Halil","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8252-6975","authenticated-orcid":false,"given":"Fatma Meri\u00e7","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2858-6229","authenticated-orcid":false,"given":"\u0130hsan","family":"Ate\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"6102_CR1","doi-asserted-by":"publisher","unstructured":"Bilgin M, Akkaya E, Dokuyucu R. Inflammatory and metabolic predictors of mortality in pulmonary thromboembolism: a focus on the triglyceride-glucose index and pan-immune inflammation Value. J Clin Med. 2024;13(19). https:\/\/doi.org\/10.3390\/jcm13196008.","DOI":"10.3390\/jcm13196008"},{"key":"6102_CR2","doi-asserted-by":"publisher","unstructured":"Segmen F, Aydemir S, Kucuk O, Dokuyucu R. The roles of vitamin D levels, Gla-Rich Protein (GRP) and Matrix Gla Protein (MGP), and inflammatory markers in predicting mortality in intensive care patients: A New Biomarker Link? Metabolites. 2024;14(11). https:\/\/doi.org\/10.3390\/metabo14110620.","DOI":"10.3390\/metabo14110620"},{"issue":"5","key":"6102_CR3","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","volume":"42","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003;42(5):1050\u201365. https:\/\/doi.org\/10.1161\/01.HYP.0000102971.85504.7c.","journal-title":"Hypertension"},{"key":"6102_CR4","doi-asserted-by":"publisher","first-page":"959285","DOI":"10.3389\/fcvm.2022.959285","volume":"9","author":"AV Poznyak","year":"2022","unstructured":"Poznyak AV, Sadykhov NK, Kartuesov AG, Borisov EE, Melnichenko AA, Grechko AV, et al. Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment. Front Cardiovasc Med. 2022;9:959285. https:\/\/doi.org\/10.3389\/fcvm.2022.959285.","journal-title":"Front Cardiovasc Med"},{"issue":"23","key":"6102_CR5","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/eurheartj\/ehac395","volume":"44","author":"L Lauder","year":"2023","unstructured":"Lauder L, Mahfoud F, Azizi M, Bhatt DL, Ewen S, Kario K, et al. Hypertension management in patients with cardiovascular comorbidities. Eur Heart J. 2023;44(23):2066\u201377. https:\/\/doi.org\/10.1093\/eurheartj\/ehac395.","journal-title":"Eur Heart J"},{"issue":"12","key":"6102_CR6","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstrom M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874\u20132071. https:\/\/doi.org\/10.1097\/HJH.0000000000003480.","journal-title":"J Hypertens"},{"key":"6102_CR7","doi-asserted-by":"publisher","unstructured":"Gusev E, Sarapultsev A. Atherosclerosis and inflammation: insights from the theory of general pathological processes. Int J Mol Sci. 2023;24(9). https:\/\/doi.org\/10.3390\/ijms24097910.","DOI":"10.3390\/ijms24097910"},{"key":"6102_CR8","doi-asserted-by":"publisher","unstructured":"Frak W, Wojtasinska A, Lisinska W, Mlynarska E, Franczyk B, Rysz J. Pathophysiology of cardiovascular diseases: new insights into molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease. Biomedicines. 2022;10(8). https:\/\/doi.org\/10.3390\/biomedicines10081938.","DOI":"10.3390\/biomedicines10081938"},{"key":"6102_CR9","doi-asserted-by":"publisher","unstructured":"Madaudo C, Coppola G, Parlati ALM, Corrado E. Discovering Inflammation in Atherosclerosis: Insights from Pathogenic Pathways to Clinical Practice. Int J Mol Sci. 2024;25(11). https:\/\/doi.org\/10.3390\/ijms25116016.","DOI":"10.3390\/ijms25116016"},{"key":"6102_CR10","doi-asserted-by":"publisher","first-page":"100909","DOI":"10.1016\/j.ijcha.2021.100909","volume":"37","author":"CD Saydam","year":"2021","unstructured":"Saydam CD. Subclinical cardiovascular disease and utility of coronary artery calcium score. Int J Cardiol Heart Vasc. 2021;37:100909. https:\/\/doi.org\/10.1016\/j.ijcha.2021.100909.","journal-title":"Int J Cardiol Heart Vasc"},{"key":"6102_CR11","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-4433105\/v1","author":"M Naghavi","year":"2024","unstructured":"Naghavi M, Reeves A, Atlas K, Zhang C, Atlas T, Henschke C, et al. AI-enabled Cardiac Chambers Volumetry and Calcified Plaque Characterization in Coronary Artery Calcium (CAC) Scans (AI-CAC) Significantly Improves on Agatston CAC Score for Predicting All Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis. Res Sq. 2024. https:\/\/doi.org\/10.21203\/rs.3.rs-4433105\/v1.","journal-title":"Res Sq"},{"issue":"11","key":"6102_CR12","doi-asserted-by":"publisher","first-page":"101300","DOI":"10.1016\/j.jacadv.2024.101300","volume":"3","author":"M Naghavi","year":"2024","unstructured":"Naghavi M, Reeves AP, Atlas KC, Zhang C, Li D, Atlas T, et al. AI-Enabled CT Cardiac Chamber Volumetry Predicts Atrial Fibrillation and Stroke Comparable to MRI. JACC Adv. 2024;3(11):101300. https:\/\/doi.org\/10.1016\/j.jacadv.2024.101300.","journal-title":"JACC Adv"},{"issue":"2","key":"6102_CR13","doi-asserted-by":"publisher","first-page":"e014788","DOI":"10.1161\/CIRCIMAGING.122.014788","volume":"16","author":"HS Bhatia","year":"2023","unstructured":"Bhatia HS, McClelland RL, Denenberg J, Budoff MJ, Allison MA, Criqui MH. Coronary Artery Calcium Density and Cardiovascular Events by Volume Level: The MESA. Circ Cardiovasc Imaging. 2023;16(2):e014788. https:\/\/doi.org\/10.1161\/CIRCIMAGING.122.014788.","journal-title":"Circ Cardiovasc Imaging"},{"key":"6102_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.amjcard.2022.06.012","volume":"179","author":"HS Bhatia","year":"2022","unstructured":"Bhatia HS, McClelland RL, Heckbert SR, Criqui M, Garg P. Density of Calcified Coronary Artery Plaque and Risk of Incident Atrial Fibrillation (from the Multiethnic Study of Atherosclerosis). Am J Cardiol. 2022;179:39\u201345. https:\/\/doi.org\/10.1016\/j.amjcard.2022.06.012.","journal-title":"Am J Cardiol"},{"issue":"3","key":"6102_CR15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","volume":"165","author":"C Romere","year":"2016","unstructured":"Romere C, Duerrschmid C, Bournat J, Constable P, Jain M, Xia F, et al. Asprosin, a Fasting-Induced Glucogenic Protein Hormone. Cell. 2016;165(3):566\u201379. https:\/\/doi.org\/10.1016\/j.cell.2016.02.063.","journal-title":"Cell"},{"key":"6102_CR16","doi-asserted-by":"publisher","first-page":"1101091","DOI":"10.3389\/fendo.2022.1101091","volume":"13","author":"M Farrag","year":"2022","unstructured":"Farrag M, Ait Eldjoudi D, Gonzalez-Rodriguez M, Cordero-Barreal A, Ruiz-Fernandez C, Capuozzo M, et al. Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects. Front Endocrinol (Lausanne). 2022;13:1101091. https:\/\/doi.org\/10.3389\/fendo.2022.1101091.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6102_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cytogfr.2021.05.002","volume":"60","author":"K Shabir","year":"2021","unstructured":"Shabir K, Brown JE, Afzal I, Gharanei S, Weickert MO, Barber TM, et al. Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence. Cytokine Growth Factor Rev. 2021;60:120\u201332. https:\/\/doi.org\/10.1016\/j.cytogfr.2021.05.002.","journal-title":"Cytokine Growth Factor Rev"},{"key":"6102_CR18","doi-asserted-by":"publisher","unstructured":"Mazur-Bialy AI. Asprosin-a fasting-induced, glucogenic, and orexigenic adipokine as a new promising player. will it be a new factor in the treatment of obesity, diabetes, or infertility? A Review of the Literature. Nutrients. 2021;13(2). https:\/\/doi.org\/10.3390\/nu13020620.","DOI":"10.3390\/nu13020620"},{"issue":"1","key":"6102_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12902-024-01560-1","volume":"24","author":"J Cui","year":"2024","unstructured":"Cui J, Liu Y, Li M, Yin J, Yang J, Xu L. Association of serum asprosin with metabolic dysfunction-associated fatty liver disease in older adult type 2 diabetic patients: a cross-sectional study. BMC Endocr Disord. 2024;24(1):27. https:\/\/doi.org\/10.1186\/s12902-024-01560-1.","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"6102_CR20","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/jdi.14162","volume":"15","author":"D Liang","year":"2024","unstructured":"Liang D, Shi G, Xu M, Yin J, Liu Y, Yang J, et al. The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community. J Diabetes Investig. 2024;15(5):608\u201313. https:\/\/doi.org\/10.1111\/jdi.14162.","journal-title":"J Diabetes Investig"},{"key":"6102_CR21","doi-asserted-by":"publisher","first-page":"6622129","DOI":"10.1155\/2021\/6622129","volume":"2021","author":"T Hong","year":"2021","unstructured":"Hong T, Li JY, Wang YD, Qi XY, Liao ZZ, Bhadel P, et al. High Serum Asprosin Levels Are Associated with Presence of Metabolic Syndrome. Int J Endocrinol. 2021;2021:6622129. https:\/\/doi.org\/10.1155\/2021\/6622129.","journal-title":"Int J Endocrinol"},{"issue":"4","key":"6102_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1055\/a-2033-6109","volume":"55","author":"IS Nedeva","year":"2023","unstructured":"Nedeva IS, Assyov Y, Karamfilova V, Vodenicharov V, Gerganova A, Hristova J, et al. Circulating Asprosin Concentrations in Patients with Obesity and Carbohydrate Disturbances. Horm Metab Res. 2023;55(4):284\u20139. https:\/\/doi.org\/10.1055\/a-2033-6109.","journal-title":"Horm Metab Res"},{"key":"6102_CR23","doi-asserted-by":"publisher","unstructured":"Askin L, Tanriverdi O, Baris VO, G\u00fcler \u00d6, Sakalli S. Asprosin in cardiovascular disease: mechanistic insights, context-dependent effects, and translational perspectives. Cardiovasc Innovations Appl. 2026;11(1). https:\/\/doi.org\/10.15212\/cvia.2026.0012.","DOI":"10.15212\/cvia.2026.0012"},{"key":"6102_CR24","doi-asserted-by":"publisher","first-page":"9735508","DOI":"10.1155\/ije\/9735508","volume":"2024","author":"H Yang","year":"2024","unstructured":"Yang H, Chen M, Liu S, Zhang Y, Wang L, Duan L, et al. Association Between the Serum Level of Asprosin and Metabolic Parameters in Adult Growth Hormone Deficiency: A Cross-Sectional Study. Int J Endocrinol. 2024;2024:9735508. https:\/\/doi.org\/10.1155\/ije\/9735508.","journal-title":"Int J Endocrinol"},{"issue":"3Supplementary","key":"6102_CR25","first-page":"1039","volume":"34","author":"N Shafi","year":"2021","unstructured":"Shafi N, Bano F, Uraneb S. The role of novel hormone asprosin in insulin resistance during preeclampsia. Pak J Pharm Sci. 2021;34(3Supplementary):1039\u201343.","journal-title":"Pak J Pharm Sci"},{"issue":"16","key":"6102_CR26","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1161\/CIRCULATIONAHA.124.070087","volume":"150","author":"P Libby","year":"2024","unstructured":"Libby P. Pathogenesis of Atherothrombotic Events: From Lumen to Lesion and Beyond. Circulation. 2024;150(16):1217\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.070087.","journal-title":"Circulation"},{"issue":"31","key":"6102_CR27","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1093\/eurheartj\/ehz961","volume":"41","author":"L Liberale","year":"2020","unstructured":"Liberale L, Montecucco F, Tardif JC, Libby P, Camici GG. Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease. Eur Heart J. 2020;41(31):2974\u201382. https:\/\/doi.org\/10.1093\/eurheartj\/ehz961.","journal-title":"Eur Heart J"},{"key":"6102_CR28","doi-asserted-by":"publisher","first-page":"112579","DOI":"10.1016\/j.biopha.2021.112579","volume":"146","author":"SR Ngcobo","year":"2022","unstructured":"Ngcobo SR, Nkambule BB, Nyambuya TM, Mokgalaboni K, Ntsethe A, Mxinwa V, et al. Activated monocytes as a therapeutic target to attenuate vascular inflammation and lower cardiovascular disease-risk in patients with type 2 diabetes: A systematic review of preclinical and clinical studies. Biomed Pharmacother. 2022;146:112579. https:\/\/doi.org\/10.1016\/j.biopha.2021.112579.","journal-title":"Biomed Pharmacother"},{"key":"6102_CR29","doi-asserted-by":"publisher","first-page":"109562","DOI":"10.1016\/j.jnutbio.2023.109562","volume":"126","author":"R Castro","year":"2024","unstructured":"Castro R, Kalecky K, Huang NK, Petersen K, Singh V, Ross AC, et al. A very-low carbohydrate content in a high-fat diet modifies the plasma metabolome and impacts systemic inflammation and experimental atherosclerosis. J Nutr Biochem. 2024;126:109562. https:\/\/doi.org\/10.1016\/j.jnutbio.2023.109562.","journal-title":"J Nutr Biochem"},{"issue":"3","key":"6102_CR30","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/oby.23656","volume":"31","author":"Y Lu","year":"2023","unstructured":"Lu Y, Yuan W, Xiong X, Huang Q, Chen S, Yin T, et al. Asprosin aggravates vascular endothelial dysfunction via disturbing mitochondrial dynamics in obesity models. Obes (Silver Spring). 2023;31(3):732\u201343. https:\/\/doi.org\/10.1002\/oby.23656.","journal-title":"Obes (Silver Spring)"},{"issue":"1","key":"6102_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12933-022-01457-0","volume":"21","author":"M You","year":"2022","unstructured":"You M, Liu Y, Wang B, Li L, Zhang H, He H, et al. Asprosin induces vascular endothelial-to-mesenchymal transition in diabetic lower extremity peripheral artery disease. Cardiovasc Diabetol. 2022;21(1):25. https:\/\/doi.org\/10.1186\/s12933-022-01457-0.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"6102_CR32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1177\/0300060513516944","volume":"42","author":"F Sefil","year":"2014","unstructured":"Sefil F, Ulutas KT, Dokuyucu R, Sumbul AT, Yengil E, Yagiz AE, et al. Investigation of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus. J Int Med Res. 2014;42(2):581\u20138. https:\/\/doi.org\/10.1177\/0300060513516944.","journal-title":"J Int Med Res"},{"key":"6102_CR33","doi-asserted-by":"publisher","unstructured":"Bilgin M, Akkaya E, Dokuyucu R. Evaluation of Inflammatory Markers in Predicting Coronary Complexity: Insights from the SYNTAX II Score in NSTEMI Patients. J Clin Med. 2024;13(19). https:\/\/doi.org\/10.3390\/jcm13195940.","DOI":"10.3390\/jcm13195940"},{"key":"6102_CR34","doi-asserted-by":"publisher","first-page":"1443749","DOI":"10.3389\/fmed.2024.1443749","volume":"11","author":"Z Chen","year":"2024","unstructured":"Chen Z, Li W, Tang Y, Zhou P, He Q, Deng Z. The neutrophil-lymphocyte ratio predicts all-cause and cardiovascular mortality among United States adults with COPD: results from NHANES 1999\u20132018. Front Med (Lausanne). 2024;11:1443749. https:\/\/doi.org\/10.3389\/fmed.2024.1443749.","journal-title":"Front Med (Lausanne)"},{"key":"6102_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-024-02490-7","author":"S Tani","year":"2024","unstructured":"Tani S, Imatake K, Suzuki Y, Yagi T, Takahashi A. Association of aerobic exercise habits with higher albumin-globulin ratio and lower cellular immune-inflammatory markers: implication of the preventive effect of aerobic exercise on atherosclerotic cardiovascular disease. Heart Vessels. 2024. https:\/\/doi.org\/10.1007\/s00380-024-02490-7.","journal-title":"Heart Vessels"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06102-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06102-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06102-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T01:41:51Z","timestamp":1786930911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06102-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6102"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06102-2","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee. All participants provided informed consent prior to enrollment.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"707"}}